197 related articles for article (PubMed ID: 27837030)
1. Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers.
Arora A; Parvathaneni S; Aleskandarany MA; Agarwal D; Ali R; Abdel-Fatah T; Green AR; Ball GR; Rakha EA; Ellis IO; Sharma S; Madhusudan S
Mol Cancer Ther; 2017 Jan; 16(1):239-250. PubMed ID: 27837030
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Moseley PM; Aleskandarany MA; Green AR; Ball G; Alshareeda AT; Rakha EA; Chan SY; Ellis IO; Madhusudan S
Mol Cancer Ther; 2015 Apr; 14(4):1057-65. PubMed ID: 25673821
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers.
Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Croteau DL; Moseley PM; Hameed K; Green A; Aleskandarany MA; Rakha EA; Patterson K; Ball G; Chan SY; Ellis IO; Bohr VA; Bryant HE; Madhusudan S
Carcinogenesis; 2016 Jan; 37(1):63-71. PubMed ID: 26586793
[TBL] [Abstract][Full Text] [Related]
4. The level of RECQL1 expression is a prognostic factor for epithelial ovarian cancer.
Matsushita Y; Yokoyama Y; Yoshida H; Osawa Y; Mizunuma M; Shigeto T; Futagami M; Imaizumi T; Mizunuma H
J Ovarian Res; 2014 Nov; 7():107. PubMed ID: 25424877
[TBL] [Abstract][Full Text] [Related]
5. Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.
Abdel-Fatah TM; Albarakati N; Bowell L; Agarwal D; Moseley P; Hawkes C; Ball G; Chan S; Ellis IO; Madhusudan S
Breast Cancer Res Treat; 2013 Dec; 142(3):515-27. PubMed ID: 24253812
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of ATM-Chk2 expression in sporadic breast cancers: a comprehensive analysis in large cohorts.
Abdel-Fatah TM; Arora A; Alsubhi N; Agarwal D; Moseley PM; Perry C; Doherty R; Chan SY; Green AR; Rakha E; Ball G; Ellis IO; Madhusudan S
Neoplasia; 2014 Nov; 16(11):982-91. PubMed ID: 25425972
[TBL] [Abstract][Full Text] [Related]
7. RECQL1 DNA repair helicase: a potential therapeutic target and a proliferative marker against ovarian cancer.
Sanada S; Futami K; Terada A; Yonemoto K; Ogasawara S; Akiba J; Yasumoto M; Sumi A; Ushijima K; Kamura T; Furuichi Y; Yano H
PLoS One; 2013; 8(8):e72820. PubMed ID: 23951333
[TBL] [Abstract][Full Text] [Related]
8. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
[TBL] [Abstract][Full Text] [Related]
9. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma.
Futami K; Ogasawara S; Goto H; Yano H; Furuichi Y
Int J Mol Med; 2010 Apr; 25(4):537-45. PubMed ID: 20198302
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer.
Abdel-Fatah TM; Perry C; Moseley P; Johnson K; Arora A; Chan S; Ellis IO; Madhusudan S
Breast Cancer Res Treat; 2014 Feb; 143(3):411-21. PubMed ID: 24381055
[TBL] [Abstract][Full Text] [Related]
11. RECQL4 helicase has oncogenic potential in sporadic breast cancers.
Arora A; Agarwal D; Abdel-Fatah TM; Lu H; Croteau DL; Moseley P; Aleskandarany MA; Green AR; Ball G; Rakha EA; Chan SY; Ellis IO; Wang LL; Zhao Y; Balajee AS; Bohr VA; Madhusudan S
J Pathol; 2016 Mar; 238(4):495-501. PubMed ID: 26690729
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of RecQL1 helicase siRNA in mouse xenograft models.
Futami K; Kumagai E; Makino H; Sato A; Takagi M; Shimamoto A; Furuichi Y
Cancer Sci; 2008 Jun; 99(6):1227-36. PubMed ID: 18422747
[TBL] [Abstract][Full Text] [Related]
13. CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy.
Alfarsi LH; Ansari RE; Craze ML; Toss MS; Masisi B; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Dec; 178(3):535-544. PubMed ID: 31471836
[TBL] [Abstract][Full Text] [Related]
14. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
[TBL] [Abstract][Full Text] [Related]
15. RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1.
Abu-Libdeh B; Jhujh SS; Dhar S; Sommers JA; Datta A; Longo GM; Grange LJ; Reynolds JJ; Cooke SL; McNee GS; Hollingworth R; Woodward BL; Ganesh AN; Smerdon SJ; Nicolae CM; Durlacher-Betzer K; Molho-Pessach V; Abu-Libdeh A; Meiner V; Moldovan GL; Roukos V; Harel T; Brosh RM; Stewart GS
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35025765
[TBL] [Abstract][Full Text] [Related]
16. FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1.
Mouron S; Manso L; Caleiras E; Rodriguez-Peralto JL; Rueda OM; Caldas C; Colomer R; Quintela-Fandino M; Bueno MJ
Breast Cancer Res; 2021 Feb; 23(1):21. PubMed ID: 33579347
[TBL] [Abstract][Full Text] [Related]
17. Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer.
Alfarsi LH; Elansari R; Toss MS; Diez-Rodriguez M; Nolan CC; Ellis IO; Rakha EA; Green AR
Breast Cancer Res Treat; 2019 Jan; 173(1):93-102. PubMed ID: 30306428
[TBL] [Abstract][Full Text] [Related]
18. Induction of mitotic cell death in cancer cells by small interference RNA suppressing the expression of RecQL1 helicase.
Futami K; Kumagai E; Makino H; Goto H; Takagi M; Shimamoto A; Furuichi Y
Cancer Sci; 2008 Jan; 99(1):71-80. PubMed ID: 17953710
[TBL] [Abstract][Full Text] [Related]
19. RECQL1 plays an important role in the development of tongue squamous cell carcinoma.
Tao J; Tao S; Han J; Zhou Z; Zhang X; Wang H; Chen R; Ji F; Zhu Y
Cell Physiol Biochem; 2014; 33(5):1579-90. PubMed ID: 24854846
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.
Kenny FS; Hui R; Musgrove EA; Gee JM; Blamey RW; Nicholson RI; Sutherland RL; Robertson JF
Clin Cancer Res; 1999 Aug; 5(8):2069-76. PubMed ID: 10473088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]